2015
DOI: 10.1007/s10006-015-0522-5
|View full text |Cite
|
Sign up to set email alerts
|

Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol—report of three cases

Abstract: This results show that this combination of drugs is beneficial in cases of bone necrosis induced by radiation, avoiding more aggressive treatments and reducing morbidity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
21
0
4

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(25 citation statements)
references
References 29 publications
0
21
0
4
Order By: Relevance
“…To treat these patients, in addition to antimicrobial therapy, oral 400 mg/day pentoxifylline and 400 mg/day tocopherol were prescribed. At the end of a 10-month follow-up, it was reported that the exposed bone surfaces shrank by 76% and all of the patients' complaints decreased (19). In a case report published by Magremanne et al, a jaw necrosis due to bisphosphonate use at stage 3 in the left lower jaw was detected.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…To treat these patients, in addition to antimicrobial therapy, oral 400 mg/day pentoxifylline and 400 mg/day tocopherol were prescribed. At the end of a 10-month follow-up, it was reported that the exposed bone surfaces shrank by 76% and all of the patients' complaints decreased (19). In a case report published by Magremanne et al, a jaw necrosis due to bisphosphonate use at stage 3 in the left lower jaw was detected.…”
Section: Discussionmentioning
confidence: 94%
“…These two drugs show a potent antifibrotic effect together. Studies have reported that the combination of pentoxifylline and tocopherol significantly decreases the chronic damage caused by radiotherapy (19). Epstein et al published a case series of jaw osteonecrosis in six patients, due to use of ZA, ibandronic acid and alendronate.…”
Section: Discussionmentioning
confidence: 99%
“…Antioxidants such as ascorbic acid (vitamin C), α-lipoic acid, and misoprostol have been shown in animal models to lessen the damage to bone after RT [60][61][62]. Vitamin E, or tocopherol, is another antioxidant shown to act synergistically with pentoxifylline, a phosphodiesterase inhibitor that acts to vasodilate and inhibit inflammatory reactions, to reduce chronic damage from RT [63,64]. A case series by Bohn et al showed successful treatment of mandible osteoradionecrosis using this combination of medications [63].…”
Section: Future Directions For Fracture Prevention: Medical Erapiesmentioning
confidence: 99%
“…Vitamin E, or tocopherol, is another antioxidant shown to act synergistically with pentoxifylline, a phosphodiesterase inhibitor that acts to vasodilate and inhibit inflammatory reactions, to reduce chronic damage from RT [63,64]. A case series by Bohn et al showed successful treatment of mandible osteoradionecrosis using this combination of medications [63]. Another study by Robard et al similarly showed improvement in osteoradionecrosis of the mandible using pentoxifylline and tocopherol with the addition of clodronate [65].…”
Section: Future Directions For Fracture Prevention: Medical Erapiesmentioning
confidence: 99%
“…PTX was originally used as a hemorheologic drug to treat intermittent claudication, with minor side effects [16]. Previous studies report positive effects of PTX alone or in combination with other drugs on some pathologic bone diseases including osteoradionecrosis, arthritis; as well as an ability to accelerate osteogensis and fracture healing in both animal models and human patients [1718192021222324252627]. However, only a few studies have elucidated the effects of PTX on osteoporotic cells in vitro or in cases of corticosteroid-induced OP.…”
mentioning
confidence: 99%